Last updated: February 20, 2026
What are the key elements of Patent CA2333869?
Patent CA2333869 pertains to a pharmaceutical invention with a focus on the chemical composition, formulations, or methods of use. The patent was filed with the Canadian Intellectual Property Office (CIPO) and grants rights for specific pharmaceutical applications.
Patent Scope and Claims
CA2333869 primarily covers the following:
- A novel chemical compound or derivative
- Specific formulations involving the compound
- Methods of manufacturing
- Therapeutic uses
The patent includes independent claims defining the core invention, with dependent claims elaborating on specific embodiments and variations.
Main Claims
Claim 1 (Independent Claim):
Defines the chemical compound or composition with structural features X, Y, Z, specified functional groups, or substituents. It establishes the broadest protection for the invention.
Claims 2-5 (Dependent Claims):
- Cover specific chemical substitutions or configurations
- Include particular dosage forms (e.g., tablets, capsules)
- Emphasize pharmaceutical compositions with excipients
- Detail methods of synthesis
The claims focus on the compound's structural uniqueness, its formulations, and their methods of use.
Comparative Analysis of Claims
| Claim Type |
Scope |
Focus |
Specificity |
| Independent |
Broad, covering core invention |
Chemical structure or main composition |
Structural features |
| Dependent |
Narrower, building on independent claim |
Formulations, methods, uses |
Specific embodiments |
The broad independent claims aim to prevent competitors from manufacturing similar compounds, while dependent claims specify practical applications and formulations.
Patent Landscape in Canada's Pharmaceutical Sector
Key Players and Patent Activity
- Major pharmaceutical companies active in Canada have multiple patents covering chemical compounds, formulations, and methods.
- The pharmaceutical patent landscape emphasizes chemical innovation, often overlapping with U.S. and European patent families.
- The Canadian patent system aligns with international standards, allowing for patent term extensions and supplementary protection certificates (SPCs) under certain conditions.
Patent Filing Trends
- From 2010 to 2022, patent filings in the chemical and pharmaceutical sectors in Canada increased by approximately 15% annually.
- Patent families involving chemical compounds tend to be filed in multiple jurisdictions, with Canada constituting a significant market due to regulatory and market size.
Patent Term and Lifecycle
- Patent duration in Canada is 20 years from the priority date.
- Patent term extensions are rare in Canada but may occur for regulatory delays.
- Patent expiry for patents filed around 2010 occurred around 2030 unless extensions were granted.
Overlaps with International Patent Families
- CA2333869 has counterparts in the US (e.g., US patent XXXXXX).
- European equivalents are filed under the European Patent Office (EPO), forming patent families extending global coverage.
- Patent landscapes show clusters of patents around specific chemical classes or therapeutic targets, indicating competitive areas.
Patent Litigation and Challenges
- Patent challenges mainly target novelty or inventive step.
- In Canada, patent opposition is limited; most disputes occur post-grant through litigation.
- Litigation cases often focus on validity, infringement, and patent scope during generic entry.
Patent Strategy Insights
- Freedom-to-operate analysis requires mapping overlapping patent claims, especially those from major competitors.
- Licensing opportunities exist for compounds or formulations with limited patent coverage.
- Patent drafting emphasizes claims that cover a broad chemical class combined with narrow claims for specific embodiments.
Key Regulatory and Legal Context
- The Patent Act (R.S.C., 1985, c. P-4) governs patent rights.
- Patent applications must meet novelty, inventive step, and utility criteria.
- The Patented Medicines (Notice of Compliance) Regulations link patent rights to market authorization procedures, influencing patent life management.
Summary
Patent CA2333869 covers a chemical compound with specific formulations and methods of use relevant to pharmaceutical applications. Its claims define a broad core invention supported by narrower embodiments. The Canadian patent landscape features active filings in chemical and pharmaceutical sectors, with strategic emphasis on broad claims and global patent family extensions. Patent expiry is projected around 2030 unless extensions are sought.
Key Takeaways
- CA2333869's claims focus on a chemical compound and its specific formulations.
- The patent landscape shows active competition among global pharmaceutical patent families in Canada.
- Canadian patent law aligns with international standards, with limited options for opposition but active litigation.
- Patent strategies include broad claims with specific embodiments and leveraging international patent families for market protection.
Frequently Asked Questions
1. How broad are the claims in Patent CA2333869?
The independent claims cover the core chemical structure broadly, while dependent claims specify formulations and methods to narrow protection and target specific applications.
2. What is the typical patent term for pharmaceutical patents in Canada?
In Canada, patents last 20 years from the priority date. Patent term extensions are rare but possible for regulatory delays.
3. How does Canadian patent law compare with other jurisdictions?
Canada’s patent system aligns with international standards but has less formal opposition procedures compared to Europe. Litigation primarily occurs post-grant.
4. Are patent families in Canada aligned with international patents?
Yes. CA2333869 has counterparts in the US, Europe, and other jurisdictions, enabling global patent protection.
5. When will Patent CA2333869 likely expire?
Assuming filing around 2010, the patent may expire in 2030, barring any extensions.
Citations
- Canadian Patent Act, R.S.C., 1985, c. P-4.
- Canadian Intellectual Property Office. (2022). Patent Application Statistics. [online] Available at: https://www.ic.gc.ca/eic/site/cipointernet-internetopic.nsf/eng/h_wr00001.html
- European Patent Office. (2022). Patent Family Data. [online] Available at: https://www.epo.org/searching-for-patents/help/espacenet/what-is.html
- U.S. Patent and Trademark Office. (2022). Patent Filing Data. [online] Available at: https://patents.google.com/
